Section Arrow
Quote
BIAF.NASDAQ
- bioAffinity Technologies Inc
Quotes are at least 15-min delayed:2026/05/14 15:21 EDT
Regular Hours
Last
 1.98
+0.09 (+4.76%)
Day High 
1.99 
Prev. Close
1.89 
1-M High
3.24 
Volume 
127.48K 
Bid
1.97
Ask
1.99
Day Low
1.87 
Open
1.88 
1-M Low
1.81 
Market Cap 
8.50M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.07 
20-SMA 2.3 
50-SMA 2.66 
52-W High 14.997 
52-W Low 0.693 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.66/--
Enterprise Value
9.28M
Balance Sheet
Book Value Per Share
1.62
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.11M
Operating Revenue Per Share
0.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QUCYQuantum Cyber NV2.763+1.423+106.19%-- 
MDXHMDxHealth SA0.97-0.98-50.26%-- 
DHRDanaher Corp165.45-0.54-0.33%32.04PE
PSNLPersonalis6.815+0.425+6.65%-- 
QGENQiagen NV33.32+0.62+1.90%16.97PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flowcytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.